158 related articles for article (PubMed ID: 32777298)
41. [Personalized drug therapy based on genetics. Possibilities and examples from clinical practice].
Stingl JC; Just KS; Kaumanns K; Schurig-Urbaniak M; Scholl C; von Mallek D; Brockmöller J
Internist (Berl); 2016 Mar; 57(3):289-97. PubMed ID: 26830424
[TBL] [Abstract][Full Text] [Related]
42. Meaningful use and clinical utility of preemptive pharmacogenetic testing: (re)view from a CYP2D6 poor metabolizer.
Leeder JS
Clin Pharmacol Ther; 2015 Feb; 97(2):119-21. PubMed ID: 25670513
[TBL] [Abstract][Full Text] [Related]
43. Unveiling the guidance heterogeneity for genome-informed drug treatment interventions among regulatory bodies and research consortia.
Koutsilieri S; Tzioufa F; Sismanoglou DC; Patrinos GP
Pharmacol Res; 2020 Mar; 153():104590. PubMed ID: 31830522
[TBL] [Abstract][Full Text] [Related]
44. Comparison of clinical pharmacogenetic recommendations across therapeutic areas.
Shugg T; Pasternak AL; Luzum JA
Pharmacogenet Genomics; 2022 Feb; 32(2):51-59. PubMed ID: 34412102
[TBL] [Abstract][Full Text] [Related]
45. Knowledge and attitudes on pharmacogenetics among pediatricians.
Rahawi S; Naik H; Blake KV; Owusu Obeng A; Wasserman RM; Seki Y; Funanage VL; Oishi K; Scott SA
J Hum Genet; 2020 May; 65(5):437-444. PubMed ID: 31983733
[TBL] [Abstract][Full Text] [Related]
46. [Pharmacogenetics in daily practice].
van Gelder T; van Schaik RHN
Ned Tijdschr Geneeskd; 2020 Jun; 164():. PubMed ID: 32608920
[TBL] [Abstract][Full Text] [Related]
47. Pharmacogenetic testing and therapeutic drug monitoring are complementary tools for optimal individualization of drug therapy.
Gervasini G; Benítez J; Carrillo JA
Eur J Clin Pharmacol; 2010 Aug; 66(8):755-74. PubMed ID: 20582584
[TBL] [Abstract][Full Text] [Related]
48. What is needed to incorporate clinical pharmacogenetic tests into the practice of psychopharmacotherapy?
de Leon J; Spina E
Expert Rev Clin Pharmacol; 2016; 9(3):351-4. PubMed ID: 26580456
[TBL] [Abstract][Full Text] [Related]
49. [Roles and impacts of pharmaceutical activity from 1990 to today: Literature review and research perspectives].
Malaure C; Ferrand É; André S; Bergeron M; Bussières JF
Ann Pharm Fr; 2020 Jan; 78(1):58-69. PubMed ID: 31564419
[TBL] [Abstract][Full Text] [Related]
50. A nationwide cross-sectional survey of pharmacy students on pharmacogenetic testing in The Netherlands.
Bank PC; Swen JJ; Guchelaar HJ
Pharmacogenomics; 2018 Mar; 19(4):311-319. PubMed ID: 29473451
[TBL] [Abstract][Full Text] [Related]
51. Clinical and ethical considerations in pharmacogenetic testing: views of physicians in 3 "early adopting" departments of psychiatry.
Hoop JG; Lapid MI; Paulson RM; Roberts LW
J Clin Psychiatry; 2010 Jun; 71(6):745-53. PubMed ID: 20361898
[TBL] [Abstract][Full Text] [Related]
52. A Critical Evaluation of Pharmacogenetic Information in Package Inserts for Selected Drugs Marketed in India and Its Comparison With US FDA-Approved Package Inserts.
Pai SA; Kshirsagar N
J Clin Pharmacol; 2016 Oct; 56(10):1232-42. PubMed ID: 26873003
[TBL] [Abstract][Full Text] [Related]
53. Integrating pharmacogenomics into pharmacy practice via medication therapy management.
Reiss SM;
J Am Pharm Assoc (2003); 2011; 51(6):e64-74. PubMed ID: 22001957
[TBL] [Abstract][Full Text] [Related]
54. Providing patients with information on pharmacogenetic testing.
Fleeman N; Dickson R
Nurs Stand; 2009 Jan 28-Feb 3; 23(21):46-8. PubMed ID: 19248450
[TBL] [Abstract][Full Text] [Related]
55. Can pharmacogenetics help rescue drugs withdrawn from the market?
Shah RR
Pharmacogenomics; 2006 Sep; 7(6):889-908. PubMed ID: 16981848
[TBL] [Abstract][Full Text] [Related]
56. Positive perception of pharmacogenetic testing for psychotropic medications.
Lanktree MB; Zai G; Vanderbeek LE; Giuffra DE; Smithson DS; Kipp LB; Dalseg TR; Speechley M; Kennedy JL
Hum Psychopharmacol; 2014 May; 29(3):287-91. PubMed ID: 24604560
[TBL] [Abstract][Full Text] [Related]
57. Clinical and regulatory considerations in pharmacogenetic testing.
Schuck RN; Marek E; Rogers H; Pacanowski M
Am J Health Syst Pharm; 2016 Dec; 73(23):1999-2006. PubMed ID: 27864207
[TBL] [Abstract][Full Text] [Related]
58. Community pharmacists' experience with pharmacogenetic testing.
Moaddeb J; Mills R; Haga SB
J Am Pharm Assoc (2003); 2015; 55(6):587-594. PubMed ID: 26409205
[TBL] [Abstract][Full Text] [Related]
59. Awareness regarding clinical application of pharmacogenetics among Japanese pharmacists.
Obara T; Abe S; Satoh M; Gutiérrez Ubeda SR; Yoshimachi S; Goto T
Pharmgenomics Pers Med; 2015; 8():35-41. PubMed ID: 25691815
[TBL] [Abstract][Full Text] [Related]
60. Physicians' opinions following pharmacogenetic testing for psychotropic medication.
Walden LM; Brandl EJ; Changasi A; Sturgess JE; Soibel A; Notario JF; Cheema S; Braganza N; Marshe VS; Freeman N; Tiwari AK; Kennedy JL; Müller DJ
Psychiatry Res; 2015 Oct; 229(3):913-8. PubMed ID: 26298505
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
